Loading organizations...
§ Private Profile · Cincinnati, OH, USA
Medical device company developing and licensing wearable drug delivery systems for high-volume therapies and at-home self-administration.
Enable Injections is a medical device company based in Cincinnati, Ohio, that develops wearable drug delivery systems, including the enFuse injector, designed for the self-administration of complex large-volume medications. The proprietary technology allows patients to independently administer high-volume therapies ranging from 5 to 25 milliliters at home, effectively improving overall treatment convenience and reducing injection pain. Operating under a business-to-business model, the firm licenses its wearable injector technology directly to global pharmaceutical partners for integration with their specific drug formulations. The private enterprise successfully secured $30 million in Series A funding in 2016, supported by institutional investors such as CincyTech and Cincinnati Children's Hospital. The organization's leadership team includes board members with prior executive experience at P&G, and the business was officially founded in 2010 by Mike Hooven, who previously founded AtriCure and holds 62 patents.
Enable Injections has raised $275.0M across 3 funding rounds.
Enable Injections has raised $275.0M in total across 3 funding rounds.
Enable Injections has raised $275.0M across 3 funding rounds. Most recently, it raised $30.0M Other Equity in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 7, 2026 | $30M Venture Round | Sanofi | — | Announced |
| Jan 29, 2022 | $215M Series C | Magnetar Capital | Cincinnati Children, CincyTech USA, Cintrifuse, GCM Grosvenor, Ohio Innovation Fund, Squarepoint Capital, Woody Creek Capital Partners | Announced |
| Oct 5, 2016 | $30M Series A | Simone Song | BOB COY, Cincinnati Children, Cintrifuse, Ohio Innovation Fund | Announced |
Enable Injections has raised $275.0M in total across 3 funding rounds.
Enable Injections's investors include Sanofi, Magnetar Capital, Cincinnati Children, CincyTech, Cintrifuse, GCM Grosvenor, Ohio Innovation Fund, Squarepoint Capital, Woody Creek Capital Partners, Simone Song, Bob Coy.